カイノスの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2023/01/25 | 1,152 | 1,187 | 1,075 | 1,089 | -52 | -4.6% | 269,700 |
| 2023/01/24 | 1,135 | 1,150 | 1,129 | 1,141 | +6 | +0.5% | 44,500 |
| 2023/01/23 | 1,142 | 1,143 | 1,124 | 1,135 | +1 | +0.1% | 18,800 |
| 2023/01/20 | 1,111 | 1,143 | 1,111 | 1,134 | +24 | +2.2% | 15,600 |
| 2023/01/19 | 1,098 | 1,113 | 1,098 | 1,110 | +1 | +0.1% | 5,600 |
| 2023/01/18 | 1,098 | 1,109 | 1,092 | 1,109 | +17 | +1.6% | 4,700 |
| 2023/01/17 | 1,096 | 1,099 | 1,089 | 1,092 | -8 | -0.7% | 5,500 |
| 2023/01/16 | 1,098 | 1,100 | 1,091 | 1,100 | +3 | +0.3% | 12,700 |
| 2023/01/13 | 1,097 | 1,100 | 1,096 | 1,097 | -2 | -0.2% | 2,300 |
| 2023/01/12 | 1,117 | 1,117 | 1,099 | 1,099 | -7 | -0.6% | 4,400 |
| 2023/01/11 | 1,112 | 1,120 | 1,105 | 1,106 | -14 | -1.3% | 7,200 |
| 2023/01/10 | 1,107 | 1,122 | 1,107 | 1,120 | +18 | +1.6% | 15,600 |
| 2023/01/06 | 1,097 | 1,108 | 1,094 | 1,102 | +14 | +1.3% | 3,800 |
| 2023/01/05 | 1,105 | 1,105 | 1,087 | 1,088 | -7 | -0.6% | 6,200 |
| 2023/01/04 | 1,111 | 1,119 | 1,095 | 1,095 | -23 | -2.1% | 6,600 |
| 2022/12/30 | 1,101 | 1,125 | 1,092 | 1,118 | +18 | +1.6% | 11,400 |
| 2022/12/29 | 1,104 | 1,104 | 1,084 | 1,100 | -4 | -0.4% | 4,200 |
| 2022/12/28 | 1,091 | 1,107 | 1,086 | 1,104 | +13 | +1.2% | 9,700 |
| 2022/12/27 | 1,084 | 1,091 | 1,071 | 1,091 | +8 | +0.7% | 5,800 |
| 2022/12/26 | 1,073 | 1,083 | 1,060 | 1,083 | +12 | +1.1% | 8,600 |
| 2022/12/23 | 1,065 | 1,071 | 1,053 | 1,071 | +1 | +0.1% | 7,700 |
| 2022/12/22 | 1,064 | 1,070 | 1,052 | 1,070 | +5 | +0.5% | 5,700 |
| 2022/12/21 | 1,046 | 1,067 | 1,046 | 1,065 | +3 | +0.3% | 9,900 |
| 2022/12/20 | 1,088 | 1,096 | 1,048 | 1,062 | -26 | -2.4% | 15,600 |
| 2022/12/19 | 1,097 | 1,098 | 1,085 | 1,088 | -12 | -1.1% | 4,200 |
| 2022/12/16 | 1,087 | 1,103 | 1,085 | 1,100 | +8 | +0.7% | 10,200 |
| 2022/12/15 | 1,092 | 1,095 | 1,087 | 1,092 | ±0 | ±0% | 5,400 |
| 2022/12/14 | 1,093 | 1,093 | 1,084 | 1,092 | +8 | +0.7% | 2,900 |
| 2022/12/13 | 1,106 | 1,106 | 1,081 | 1,084 | -18 | -1.6% | 9,200 |
| 2022/12/12 | 1,101 | 1,105 | 1,101 | 1,102 | +1 | +0.1% | 1,700 |
| 2022/12/09 | 1,099 | 1,102 | 1,097 | 1,101 | +8 | +0.7% | 4,300 |
| 2022/12/08 | 1,090 | 1,095 | 1,086 | 1,093 | -6 | -0.5% | 2,500 |
| 2022/12/07 | 1,076 | 1,101 | 1,072 | 1,099 | +27 | +2.5% | 10,000 |
| 2022/12/06 | 1,074 | 1,083 | 1,068 | 1,072 | -9 | -0.8% | 7,200 |
| 2022/12/05 | 1,095 | 1,095 | 1,081 | 1,081 | -20 | -1.8% | 14,800 |
| 2022/12/02 | 1,116 | 1,116 | 1,101 | 1,101 | -15 | -1.3% | 6,900 |
| 2022/12/01 | 1,124 | 1,127 | 1,115 | 1,116 | -4 | -0.4% | 8,200 |
| 2022/11/30 | 1,119 | 1,120 | 1,113 | 1,120 | +4 | +0.4% | 2,700 |
| 2022/11/29 | 1,110 | 1,116 | 1,105 | 1,116 | +1 | +0.1% | 3,700 |
| 2022/11/28 | 1,118 | 1,122 | 1,112 | 1,115 | -4 | -0.4% | 8,500 |
| 2022/11/25 | 1,146 | 1,149 | 1,117 | 1,119 | -6 | -0.5% | 24,500 |
| 2022/11/24 | 1,159 | 1,159 | 1,125 | 1,125 | -14 | -1.2% | 26,400 |
| 2022/11/22 | 1,175 | 1,175 | 1,132 | 1,139 | -24 | -2.1% | 22,900 |
| 2022/11/21 | 1,170 | 1,180 | 1,156 | 1,163 | -2 | -0.2% | 20,200 |
| 2022/11/18 | 1,152 | 1,171 | 1,143 | 1,165 | +13 | +1.1% | 15,100 |
| 2022/11/17 | 1,134 | 1,152 | 1,130 | 1,152 | +16 | +1.4% | 17,600 |
| 2022/11/16 | 1,139 | 1,141 | 1,129 | 1,136 | -3 | -0.3% | 7,900 |
| 2022/11/15 | 1,143 | 1,146 | 1,130 | 1,139 | -1 | -0.1% | 12,900 |
| 2022/11/14 | 1,101 | 1,140 | 1,101 | 1,140 | +28 | +2.5% | 25,500 |
| 2022/11/11 | 1,098 | 1,112 | 1,088 | 1,112 | +26 | +2.4% | 11,200 |
451～
500
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「カイノス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| カイノス | 120,000円 | +6.8% | -13.8% | 2.67% | 9.20倍 | 0.78倍 |
|
臨床検査薬の中堅メーカー。生化学、免疫血清学的検査用試薬に重点。共同開発の促進に注力 |
| ＶＩＳ | 89,000円 | +87.8% | +265.7% | 0.00% | 53.45倍 | 2.45倍 |
|
ｍＲＮＡ標的低分子創薬技術を製薬会社に提供。共同創薬研究などによる契約金収入が柱 |
| クリングル | 84,500円 | +240.0% | - | 0.00% | - | 2.75倍 |
|
細胞の増殖、保護、修復などの機能があるＨＧＦタンパク質を用いて、難治性疾患治療薬を開発 |
| キッズバイオ | 12,100円 | - | - | 0.00% | - | 6.37倍 |
|
北大発創薬ベンチャー。バイオ後続品を主力に、乳歯歯髄幹細胞（ＳＨＥＤ）用いた再生医療に力 |
| ブライトパス | 5,600円 | - | - | 0.00% | - | 3.94倍 |
|
久留米大学発創薬ベンチャー。がん向け遺伝子導入ｉＰＳ由来細胞医薬や抗体医薬開発に注力 |
市場注目の銘柄
チャート関連のコラム
